Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression
Loading...
Identifiers
Publication date
Authors
Aldámiz Echevarría, Teresa
Tejerina, Francisco
Fanciulli, Chiara
Díez, Cristina
Pérez, Leire
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
Lymphomas remain among the most frequent HIV-associated malignancies, with risk persisting despite effective virological control. This study describes the clinical, epidemiological and prognostic characteristics of lymphomas (both Hodgkin and non-Hodgkin) in people living with HIV, according to virological suppression at diagnosis and assesses lymphoma-related mortality at 1 year and overall survival at 5 years.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Aldámiz‐Echevarria, T., Tejerina, F., Fanciulli, C., Diez, C., Perez, L., Bellón, J. M., Espinosa, N., Guillén, S. M., Del Mar Arcos‐Rueda, M., Montero‐Alonso, M., García‐Fraile, L., Asensi, V., López, M. F., Corona‐Mata, D., Cabello‐Úbeda, A., Manso, M. G., Iribarren, J. A., Pérez‐Martínez, L., Valls, M. R. A., … CoRIS Cohort. (2026). Hodgkin and non‐Hodgkin lymphomas in the post‐antiretroviral therapy era according to HIV virological suppression. HIV Medicine, 27(8), 1312-1332. https://doi.org/10.1111/hiv.70257
Editor's version
https://doi.org/10.1111/hiv.70257Type of document
Collections
La licencia de este ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International